BioNTech SE (BNTX) Share-based Compensation Growth (1y) (2019 - 2026)
Powered by 
Analysis
BioNTech SE (BNTX) Share-based Compensation Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 71.86% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -3.46% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -7.69% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -8.89% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -22.43% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -4.01% |
| 10 | BioNTech SE | 25.06 Bn | 11.41 Bn | 10.00 Mn | -33.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.14% |
| Mar 31, 2026 | 14.83% |
| Dec 31, 2025 | 11.71% |
| Sep 30, 2025 | -27.38% |
| Jun 30, 2025 | 67.04% |
| Mar 31, 2025 | 31.28% |
| Dec 31, 2024 | 64.36% |
| Sep 30, 2024 | 166.21% |
| Jun 30, 2024 | 52.49% |
| Mar 31, 2024 | 91.83% |
| Dec 31, 2023 | -32.54% |
| Sep 30, 2023 | -72.74% |
| Jun 30, 2023 | -9.67% |
| Mar 31, 2023 | -26.57% |
| Dec 31, 2022 | -3.42% |
| Sep 30, 2022 | -15.87% |
| Jun 30, 2022 | -40.39% |
| Mar 31, 2022 | -39.76% |
| Dec 31, 2021 | 169.44% |
| Mar 31, 2021 | 125.04% |